Inventor
Huw Tanner
Inventor
San Francisco, CA, US
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07DHeterocyclic compounds25%
C07BGeneral methods of organic chemistry17%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium8%
PatentTitleYear
10,709,712Biaryl amide compounds as kinase inhibitors202010,245,267Biaryl amide compounds as kinase inhibitors20199,694,016'Biaryl amide compounds as kinase inhibitors'20179,242,969'Biaryl amide compounds as kinase inhibitors'20169,173,883'Ring-substituted N-pyridinyl amides as kinase inhibitors'20158,987,457'Ring-substituted N-pyridinyl amides as kinase inhibitors'2015Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2015–2020Patents assigned to NOVARTIS AG (6)· patent assignee history
2015–2020Based in San Francisco, CA, US· patent location history
2015–2016Based in Alameda, CA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| NOVARTIS AG | 6 | 2015–2020 |
Locations
| Location | Patents | Span |
|---|---|---|
| San Francisco, California, US | 4 | 2015–2020 |
| Alameda, California, US | 2 | 2015–2016 |